Search RHCG Website
Select your language

Traumatic Brain Injury

exp date isn't null, but text field is

Objectives

• To provide a consistent approach to TBI within PICU

• To minimise the incidence of secondary brain injury within PICU

Scope

This guideline is intended for all healthcare professionals caring for traumatic brain injury patients within the Paediatric Intensive Care Unit at the Royal Hospital for Sick Children, Glasgow.

Audience

All medical, nursing and allied professionals caring for patients who have traumatic brain injury should be familiar with the protocol.

NoteExtradural haematomas are a neurosurgical emergency. They need referred to a neurosurgeon immediately for early neurosurgical treatment. The following guidelines do not apply to extradural haemorrhage.

Introduction

Traumatic Brain injury (TBI) is a major source of mortality amongst older children. Public health measures have had the biggest impact on reduction in mortality and morbidity in recent years (safety helmets, seatbelts, speed reduction). 

The intensive care management of these injuries focus on preventing secondary injury and being alert to a surgically remedial event. This includes trying to prevent or reduce any further factors that may increase brain injury. Avoidance of hypoxia, hypotension, pyrexia and hypoglycaemia are probably the only factors that clinicians agree should be avoided. There is general acceptance that trying to minimise further swelling of the brain and control the intracranial pressure (ICP) may be useful. Therefore in some brain injuries particularly if the GCS<8 and with an abnormal CT a direct monitor for ICP may be placed.

Maintaining the cerebral perfusion pressure (CPP) of the brain is felt to be even more important.

CPP= MAP -ICP

This formula is most useful when both the ICP and MAP are directly measured. See below for age-related values.

A basic strategy for preventing secondary brain injury is good basic intensive care. Sedate and minimise oxygen demand, employ minimal handling to prevent surges in ICP, oxygenate well, maintain blood pressure (therefore keeping CPP adequate), treat pyrexia and avoid hypoglycaemia.

Until fairly recently it was standard management to hyperventilate patients and aim for a low pCO2 – this definately reduced the ICP but as it works via cerebral vasoconstriction it also reduced oxygen delivery to the brain. A more conservative approach is now taken aiming for a low normal pCO2 (4.5-5 kPa) and only resorting to hyperventilation if there are concerns of impending cerebral herniation. Judicious use of inotropes to maintain and support CPP is important. There is some evidence that noradrenaline is superior to dopamine. However it is more important to maintain CPP than differentiate between agents.

If the above basic management fails other steps may be taken to control ICP. Mannitol and hypertonic saline (osmotic diuretics) are both highly effective at reducing ICP quickly. The debate as to whether one is superior to the other continues.

If the ICP is difficult to control sometimes an external ventricular drain (EVD) will be placed by the neurosurgeon. An EVD can be technically difficult to insert in a swollen brain and may require the aid of a volume CT scan which is only performed during the day. If an EVD is present then one response to raised ICP is to let some CSF drain out and allow the ICP to normalise. (See EVD guideline).

The evidence for all secondary therapeutic measures to reduce ICP and prevent secondary brain injury is patchy at best. There was and remains great hope on the basis of animal, neonatal and adult data that therapeutic hypothermia may minimise secondary brain injury. Cooling appears to improve survival and function in both neonatal encephalopathy and post-cardiac arrest in adults. However most head injury trials have failed to correlate cooling with improved survival. The only randomised controlled trial (RCT) in paediatrics to date cooled for 24hours and found no benefit. It may be that we just don’t know how long, how quickly or how cold to cool patients as yet to be effective. Alternatively in the future it may be that cooling is discounted as a treatment strategy. Meanwhile it is common practice to undertake cooling as a secondary intervention if ICP remains problematic. If actively cooling paralysis should be commenced to prevent shivering which increases ICP and oxygen demand.

Thiopentone coma remains a standard treatment when ICP is difficult to control but needs to be undertaken carefully. Thiopentone infusion will lead to a fall in blood pressure and measures must be in place to avoid this (eg. noradrenaline). CFAM monitoring or EEG should be used in conjunction with thiopentone coma aiming for a reduction in ICP primarily or burst suppression. Thiopentone is a particularly toxic substance which has a long half-life. An irritating side-effect of thiopentone is that it may induce fixed dilated pupils. This removes one of the key areas of brain function assessment when paralysed and sedated. Brain stem testing cannot be performed until thiopentone levels have fallen. A Cochrane Review concluded that barbiturate therapy did not improve outcome in head injury

Decompressive craniectomy is an age old surgical treatment which literally allows the rigid box of the skull to be opened. This allows room for the brain to swell and therefore reduces ICP. There is concern that decompressive craniectomy may increase survival but at a very poor functioning level (eg. persisitent vegetative state). A recent randomised study DECRA did not include children and failed to reveal a positive outcome. Decompressive craniectomy may have a place in a few well selected cases, current consensus is that outcomes may be improved if decompressive craniectomy is performed early.

Intensive Care - Standard Operating Procedure (SOP) General PICU Management

The general aims of PICU management of children with severe head injuries are to meticulously maintain adequate oxygenation of the arterial blood, achieve a blood pressure that will perfuse the brain and an intracranial pressure of less than 20mmHg. It is also necessary to bear in mind continually the possibility of the development of an intracranial lesion that may require surgery.

1. General Measures
  • Elevate head of bed to 30o.
  • Head kept midline & in the neutral position (neither flexed or extended).
  • Cervical collar not impeding cerebral venous return.
  • Place oral-gastric tube. (avoid nasal route as may have basal skull fracture).
  • Meticulous attention to pressure areas. (A pressure-relieving mattress must not be used in any patient in which there are concerns regarding spinal injury).
  • Adequate drainage of urine (increased intra-abdominal pressure will ↑ ICP).
  • Cooling blanket in place if need is anticipated.
2. Airway, Breathing with C-spine control

Treat all TBI as having a C-spine injury

Oral ETT placed. (avoid nasal route as may have basal skull fracture). The aim of ventilation is to maintain adequate oxygenation with low normocapnia.

PaO2 >10 -13kPa PaCO2 4.5- 5 kPa

This should be achieved at the lowest possible PIP and PEEP (<5mmHg). 

Some literature suggest there may be a place for Pressure Regulated Volume Controlled Mode of ventilation (ie SIMV Autoflow, rather than BIPAP). More important than mode is to measure end-tidal pCO2 continuously and react to changes.

Arterial gases should be performed at least 4-6 hourly in the first few days of admission. A change in end-tidal pCO2 or rise in ICP should result in a repeat gas.

Endotracheal suctioning (ETS) may produce significant (usually transient) rises in ICP. It remains necessary, but should be minimised and some means of prophylaxis –sedation boluses ( Fentanyl 2micrograms/kg IV) or endotracheal instillation of lignocaine 1% (max 2mls)- should be considered.

C-spine – ensure correct collar placement and careful moving and handling as per APLS guidelines. Log-roll –no straight lifting. See separate moving and handling guideline.

3. Circulation

Hypotension should be considered an emergency

If adequate filling alone fails to produce an adequate blood pressure then judicious use of inotropic support will be necessary. Consider noradrenaline/ dopamine/adrenaline to titrate to BP. Arterial and central venous catheters will generally be placed to allow continual monitoring of arterial and CVP. Transducers will be levelled to the right atrium. Femoral lines are preferred in view of less disruption to cerebral venous return. Aim for a CVP 6-10mmHg.

 

Fluids: 0.9% saline (75-100% calculated maintenance) Glucose should be withheld from the IV solution if the serum glucose is above 10 mmol/l. When serum glucose reaches the normal range the IV solution should be changed to 5% dextrose/0.9% saline.

Avoid hypoglycaemia -if found treat quickly and ensure followed up carefully. Give 2ml/kg of 10% dextrose and repeat sugar at 30 mins and 1 hour minimum.

 

Electrolytes Hyponatraemia may produce further brain swelling in this context (particularly if inappropriate ADH syndrome occurs) therefore target:

[Na] at >140mmol/l and a serum osmolality of >280mOsm

Aim for normokalaemia.

Maintaining an optimal Cerebral Perfusion Pressure (CPP) is critical, as well as controlling the ICP.

 

CPP = MAP – ICP

Age

Normal ICP

values

Treatment

Threshold for ICP

Target CPP

values

 

Neonates

(or infants with

wide fontanelle)

 

 

 

1.5 – 5 mmHg

 

 

>10 mmHg

 

 

>30mmHg

 

 

0-2 years

 

 

3 –7 mmHg

 

Remains unknown

but assess whether

large fontanelle

present

 

 

 

>40mmHg

 

 

2-10 years

 

 

 

 

3 – 7 mmHg

 

 

>20mmHg

 

 

>50mmHg

 

 

>10 years

 

 

 

 

<10 – 15 mmHg

 

 

>20mmHg

 

 

>60mmHg

Agree target ICP and CPP for intervention for each individual patient with intensivist and neurosurgeon.

4. Disability

Neuro-observations must be performed regularly – every 30 minutes if an ICP monitor is not in-situ. 2 hourly if ICP monitor in place. Any changes should be alerted to a doctor.

ICP monitoring – If present be alert to changes. For set up and background to ICP -See separate ICP monitoring guideline.

If elevation of ICP is >20mmHg for >5min then move on to CONTROL ICP ALGORITHM

 

Analgesia and Sedation

Patients should receive an infusion of narcotic (morphine or fentanyl) and midazolam. Inadequate sedation should be a first consideration for raised ICP Once adequately sedated, a muscle relaxant may be added prn as a bolus to prevent coughing on suction. If cooled, paralysis should be delivered as a continous infusion to prevent shivering and its associated metabolic demands.

Seizures

Patients have a high risk of seizures which can be difficult to recognise in a sedated +/- paralysed child. Seizures increase ICP substantially, therefore a prophylactic approach has been adopted. Load with phenytoin IV (18mg/kg over 30 mins) and then continue maintenance dose for at least 7 days.

5. Temperature Management
  • Core (rectal or bladder) temperature should be monitored continually in these children. The aim should be to maintain a temperature of 36.5 -37°C using paracetamol and cooling blanket if necessary.
  • If the child is therapeutically cooled for raised ICP then they must NOT be allowed to shiver. Continous paralysis should be commenced.
  • Where possible place a second cooling blanket on top of the patient.
  • If the temperature is slow to fall consider use of cold packs, take care to monitor for cold injury, rotate frequently.
  • Be vigilant against pressure areas on cooling blankets.
  • Once target temperature reached remove 2nd blanket and ice packs.
  • See separate Blanketrol guideline for further details on set up and use of cooling blankets.

When re-warming after hypothermia:

  • Rewarm by 10C every 4 hours by setting the blanket temp up 0.5 OC every 2 hours.
  • Be vigilant that the patient does not re-warm faster.
  • Therefore in practice if at 33oC the child will take 14 hours to re-warm.
6. Nutrition
  • Enteral feeding should be considered early and should follow our standard nutrition guidelines.
  • Ranitidine 1mg/kg IV every 6 hours should be prescribed until feeds are well established.
  • Regular laxatives/aperients are started early to avoid straining. 
7. Other

Eye Care

  • Standard eye care treatment as per eye care guidelines.
  • Beware ophthalmic assessment: long-acting dilating agents are contraindicated as these mask pupillary response and render us unable to evaluate brain injury

Infection and Sepsis

  • Blood, urine and BAL cultures if pyrexial. BAL – same care as suctioning.
  • Daily CSF cultures if EVD in Situ – See separate EVD guideline. 

Laboratory Tests

  • Morning bloods: Daily U &E’s, FBC, clotting including serum osmolality.
  • 8 hourly U&E’s in first 3 days or if remains unstable.
  • Art gases- 4-6 hourly
  • If the child becomes polyuric consider diabetes insipidus – record specific gravity, send U&E’s and paired blood and urine for osmolality.- See separate Diabetes Insipidus guideline 

DVT prophylaxis

  • If child is large enough (eg > 40Kg) apply correct size TED stockings if child is immobile >48hrs (if other injuries allow).
  • Consider use of Low molecular weight heparin (enoxaparin) – discuss with neurosurgeon.
Neck Immobilisation

 In the case of a patient who has no known radiological injury to the cervical spine and who is well sedated and immobile (paralysed), the purpose of the cervical collar is to serve as a warning of a potential neck lesion. The initial hard collar should be exchanged for a suitably sized long –term collar (eg.Miami –J). The collar should be left in situ but should be left open except when the patient is being moved to scan etc. or log rolled. The head should still be protected with sandbags either side. A sign should be placed above the bed declaring “ C-spine not cleared” .The collar must not be allowed to obstruct venous return or become a source of pressure necrosis. The collar MUST be fastened up again when the child is moved, log rolled, woken up or when the paralysis is discontinued.

KEY POINTS

• Good oxygenation at all times

• Avoid / Treat aggressively any drops in Cerebral Perfusion Pressure

• If these measures fail to control ICP: elevation of ICP is >20mmHg for >5min then move on to CONTROL ICP ALGORITHM

Raised ICP Management Algorithm

Treatment threshold is a sustained ICP rise above target limit for > 5 minutes.

Ensure all general management outlined is being achieved if not correct this first.

 

 

  • Head up 30 °, head midline, no obvious venous obstruction, loosen collar if in situ
  • Keep CPP >40 if 0-2; >50 if 2-10; >60 if >10yrs
  • SpO2 > 96%; PaO2 >10-13kPa : PaCO2 4.5-5.0 kPa
  • Temp < 37 degrees
  • Sedation bolus
  • Confirm no evidence of seizure activity
  • Any pupillary changes?

 Consider mass lesion – CT SCAN & Neurosurgical Opinion

                                                  

             

First Tier Therapy

  •  In patients with EVD remove CSF – open for 5 minutes initially.

 If ICP still raised: 

  • Give Mannitol 20% (0.5g/kg (2.5ml/kg)over 15 minutes repeat as needed until plasma osmolality 320 mOsm; Na> 140) Osmotic therapy becomes less effective further away from injury.

    Or
  • Give Hypertonic saline (3%) Bolus 1-2ml/kg over 5 mins Or infusion of 0.1 -1ml/kg/hour (Caution if osmolality >320mOsm/l Contraindicated if >360 mOsm/l)
  • If mannitol/saline required → insert EVD at first opportunity

                                               

            

ICP STILL RAISED

Second Tier Therapies (all lack conclusive proof of benefit)

 

  • Hyperventilation down to Pa CO2 4 - 4.5kPa
  • Titrated hypothermia. Use cooling blanket to drop core temp by 10C at a time and reassess ICP. Typically cool patient to 33 - 34 ° centrally by cooling blanket for at least 48 hours.
  • Consider further CSF drainage ( by EVD )
  • Trial of Thiopentone- see response to bolus dose (4mg/kg); if effective in reducing ICP →start infusion ( 3-5 mg/kg/hr). CFAM monitoring. *
  • Consider raising CPP further using inotrope infusion and titrate to maintain systemic hypertension (be aware that this will increase blood flow and may increase ICP further)


               

ICP STILL RAISED or impending cerebral herniation?

 

  • Further dose of Mannitol 0.5g/kg (2.5ml/kg of 20% mannitol)
  • Hyperventilation
  • Urgent neurosurgical consultation & CT scan

 

*Thiopentone is a potent and toxic drug. It acts on GABA A and offers cerebral protection. It should be used with caution, using the smallest dose possible and titrated to effect, aiming to lower ICP. CFAM monitoring should always be used. It accumulates over time as it undergoes zero-order kinetics. Levels need to be checked prior to being able to perform brain stem testing. Alternatively propofol infusion can be considered in older children but consider carefully propofol syndrome.

 

  1. NB. Thiopentone can reduce the life-span of gas machine cartridges – if a patient is on a thiopentone infusion all samples from that patient should be run through the same gas machine. The gas machine should be labelled thiopentone. It can continue to be used for other patients.

The above is intended as a guide. It may be more appropriate in individual cases to tolerate a mildly elevated ICP (eg. 25mmHg) rather than proceed to second tier therapies.

References

1. Intracranial Pressure Monitoring Guidelines – Neurosurgical Institute Glasgow

2. Medical Management of Traumatic Brain Injuries – PICU Guidelines – Alder Hey hospital, Liverpool.

3. Guidelines for the Management of Severe Traumatic Brain Injury – Birmingham

4. The Guidelines for the Acute Medical Management of Severe Traumatic Brain Injury in Infants, Children, and Adolescents. Paed Crit Care Med Supplement-2003

5. Dean NP, Boslaugh S, Adelson PD, Pineda JA, Leonard JR et al Physicians Agreement with Evidence-Based Recommendations for the Treatment of Severe Traumatic Brain Injury Journal of Neurosurgery 2007; 107(5 Suppl): 387-91

6. The Epidemiology of Urban Paediatric Neurotrauma: Evaluation of, and Implications for,Injury Prevention Programs. Neurosurgery:Vol 42(2);300-31

7. Pediatric Brain Injuries: The Nature, Clinical Course and Early Outcomes in a Defined United States’ Population. Kraus JF,Fife D, Conroy C. Pediatrics 1987; 79: 501-507

8. Epidemiology of Traumatic Brain Injury in Children Receiving Intensive Care in the UK. Parslow RC, Morris K, Tasker R, Forsyth R, Hawley C. Archives of Diseases in Childhood 2005;90:1182-1187

9. Report of Working Party on Management of Head Injuries – RCS (Lancet 1997;349:821-4

10. Quayle KS, Jaffe DM, Kuppermann N, et al. Diagnostic testing for acute head injury in children: when are head computed tomography and skull radiographs indicated? Pediatrics 1997;99:11–17.

11. Chambers I.R, Stobbart L, Jones P.A, Kirkham F.J, Marsh M, Mendelow A.D, Minns R.A, Struthers S, Tasker R.C et al Child's Nervous System 2005; 21 (3): 195-199 Age-related differences in intracranial pressure and cerebral perfusion pressure in the first 6 hours of monitoring after childrens head injury:association with outcome

12. Philip S, Chaiwat O, Udomphorn Y, Moore A, Zimmerman J.J, Armstead W Variation in cerebral blood flow velocity with cerebral perfusion pressure >40 mm Hg in 42 children with severe traumatic brain Crit Care Med 2009(37);11:2973

13. Tume L, Baines P, Lisboa P The Effect of Nursing interventions on the Intracranial Pressure in Pediatric Traumatic Brain Injury Nursing in Critical care 2011;16:77-84

14. White H , Venkatesh B Cerebral perfusion pressure in neurotrauma: a review Anesth Analg 2008;107:979-988

15. Wakai A, Roberts I, Schierhout G Mannitol for acute traumatic brain injury. Cochrane Database Syst Rev. 2005 19;(4):CD001049.

16. Knapp JM Hyperosmolar therapy in the treatment of severe head injury in children: mannitol and hypertonic saline. AACN Clin Issues. 2005;16(2):199-211.

18. Forsyth RJ, Parslow RC, Tasker RC, Hawley CA, Morris KP Prediction of raised intracranial pressure complicating severe traumatic brain injury in children: implications for trial design. Pediatr Crit Care Med. 2008 Jan;9(1):8-14.

19.Gluckman P ,Wyatt J,Azzopardi D, Ballard D et al Selective Head Cooling with Mild Systemic Hypothermia After Neonatal Encephalopathy Lancet 2005;365:663-670

20.Denis V. Azzopardi, Brenda Strohm, A. David Edwards, Leigh Dyet, Henry L. Halliday, Moderate Hypothermia to Treat Perinatal Asphyxial Encephalopathy N Engl J Med 2009; 361:1349-1358

21. The Hypothermia after Cardiac Arrest Study Group Mild Therapeutic Hypothermia to Improve the Neurologic Outcome after Cardiac Arrest N Engl J Med 2002; 346:549-556

22. McIntyre et al Prolonged Therapeutic Hypothermia After Traumatic Brain Injury in Adults Systematic Review JAMA 2003; 289(22):2992-9

23. Henderson, Dhingra V, Chittock D, Fenwick j, Ronco J et al Hypothermia in the Management of Traumatic Brain Injury Int Care Med 2003;29 (10):1637-44

24. Sydenham E, Roberts I, Alderson P Hypothermia for traumatic head injury Cochrane 2009

25. Clifton et al Lack of effect of induction of hypothermia after acute brain injury NEJM 2001;344:556-563

26. Biswas et al Treatment of acute traumatic brain injury in children with moderate hypothermia improves intracranial hypertensionCrit Care Med 2002;30:2742-51

 27. Adelson P.D, Ragheb J, Muizelaar J, Kanev P, Brockmeyer D, Beers S et al Phase II Clinical Trial of Moderate Hypothermia after Severe Traumatic Brain Injury in Children Neurosurgery 2005;56(4):740-75

28. Hutchison JS, Ward RE, Lacroix J, Hébert PC, Barnes MA, Bohn DJ et al Hypothermia therapy after traumatic brain injury in children. NEJM 2008;358:2447-2456

29.Schierhout G, Roberts I. Anti-epileptic drugs for preventing seizures following acute traumatic brain injury. Cochrane Database Syst Rev. 2001;(4):CD000173

30. Roberts I Barbiturates for acute traumatic brain injury Cochrane Database Syst Rev. 2000;(2):CD000033.

31. Gough S, Tume L, Sinha A Efficacy of CSF Drainage on ICP Reduction After Severe Paediatric Traumatic Brain Injury. World Congress of Paediatric Critical Care, Geneva 2007 

32. Sahuquillo J Decompressive craniectomy for the treatment of refractory high intracranial pressure in traumatic brain injury Cochrane Database 2009

33. Kan P, Amini A, Hansen K, White GL Jr, Brockmeyer DL, Walker ML et al Outcomes after decompressive craniectomy for severe traumatic brain injury in children. J Neurosurg. 2006;105(5 Suppl):337-42.

34. Jagannathan J, Okonkwo DO, Dumont AS, Ahmed H, Bahari A, Prevedello DM et al Outcome following decompressive craniectomy in children with severe traumatic brain injury: a 10-year single-center experience with long-term follow up.

J Neurosurg. 2007;106(4 Suppl):268-75.

35. Cooper DJ, Rosenfeld JV, Murray L, Arabi YM, Davies AR, D'Urso P et al Decompressive craniectomy in diffuse traumatic brain injury N Engl J Med. 2011 Apr 21;364(16):1493-502

Editorial Information

Last reviewed: 01 March 2014

Next review: 30 November 2020

Author(s): J. Richardson

Co-Author(s): Anne McGettrick

Approved By: Paediatric Clinical Effectiveness & Risk Committee

Document Id: 12